THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...
The one-stage method was carried out on several hundred subjects to find the limits of variation in nonhypoprothrombinemic states. As representative samples, the results on 12 normal subjects studied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results